Search
for

    Sort by

    Research 61–90 of 284

    1. Efficacy of <i>Serenoa repens</i> lipido-sterolic extract alone or in combination with propolis polyphenols and <i>Boswellia serrata</i> extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders Archivio Italiano di Urologia e Andrologia · 2025 · 1 citations
    2. Relación entre los síntomas del tracto urinario bajo y las características anatómicas de la próstata en pacientes con obesidad y obesidad grave Cirugía y cirujanos · 2020
    3. MP24-09 MEN WITH AN IMPROVEMENT IN URINARY SYMPTOMS HAVE A LOWER RISK OF MORTALITY The Journal of Urology · 2023
    4. Lower Urinary Tract Symptoms: What’s New in Medical Treatment? European urology focus · 2018 · 22 citations
    5. Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population Urology · 2013 · 16 citations
    6. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    7. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement Urology Annals · 2024 · 2 citations
    8. Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice Nihon Yakuri Gakkai nenkai yoshishu · 2019
    9. How Much Worse Will My Voiding Symptoms Get over Time? The Journal of Urology · 2013
    10. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    11. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    12. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    13. Effect of metabolic syndrome on treatment outcome of lower urinary tract symptoms in males due to benign prostatic hyperplasia Panacea Journal of Medical Sciences · 2020 · 1 citations
    14. 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction Cochrane library · 2015 · 1 citations
    15. Editorial Comment Urology · 2012 · 1 citations
    16. Efficacy and Safety of a Proprietary Free Fatty Acid Rich Saw Palmetto Extract (USPlus<sup>®</sup> PRO) for Lower Urinary Tract Symptoms in Males: A Randomized, Double-Blind, Placebo-Controlled Trial Food and Nutrition Sciences · 2026
    17. MP09-16 5-ALPHA REDUCTASE INHIBITORS FOR MALE LOWER URINARY TRACT SYMPTOMS: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS 2017
    18. The Social Capital of Social Media: A Correlational Study of Facebook Use, Campus Attachment, and Involvement Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2011
    19. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    20. Re: Relationship Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Results From the Boston Area Community Health Survey The Journal of Urology · 2008
    21. BPH: epidemiology and comorbidities. PubMed · 2006 · 386 citations
    22. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    23. Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE 2017 · 19 citations
    24. Interactions between Lower Urinary Tract Symptoms and Cardiovascular Risk Factors Determine Distinct Patterns of Erectile Dysfunction: A Latent Class Analysis The Journal of Urology · 2013 · 12 citations
    25. Higher Levels of Serum Uric Acid Have a Significant Association with Lower Incidence of Lower Urinary Tract Symptoms in Healthy Korean Men Metabolites · 2022 · 8 citations
    26. Fesoterodine: Pharmacological properties and clinical implications European journal of pharmacology · 2018 · 5 citations
    27. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    28. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial Prostate International · 2023 · 1 citations
    29. The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review Consilium Medicum · 2025
    30. Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study 2023